In the latest bellwether case to go to trial over the osteoporosis drug Fosamax, a federal jury awarded $285,000 to a woman who suffered injuries to her jaw after using the drug, Scheinberg v. Merck & Co., Inc. (U.S. District ...

Tagged with: Fosamax

The attorney for the plaintiff in the second trial of the ongoing Fosamax litigation has filed an appeal after the judge in the case sanctioned him for his courtroom behavior. Gary Douglas, attorney for the plaintiff ...

Tagged with: attorney Fosamax sanctions

An $8 million verdict for a plaintiff who suffered from osteonecrosis of the jaw after taking Fosamax is excessive, and the plaintiff must choose between a new trial on damages or a remittitur to $1.5 million, a U.S. District Court has ruled.

Tagged with: damages Fosamax verdict

Jury selection in the third Fosamax bellwether trial is slated for Oct. 28 in U.S. District Court for the Southern District of New York. Timothy O’Brien, a shareholder in Levin, Papantonio, Thomas, Mitchell, Echsner & Proctor in Pensacola, Fla.

Tagged with: Fosamax jury selection Litigation trial

An attorney who helped win a $8 million jury verdict against Merck over its osteoporosis drug Fosamax now faces possible sanctions by the trial judge.

Tagged with: attorney Fosamax sanctions